The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide
Bibliography: Domestic Policy Issues
Optimising personalised care for adults prescribed medicines associated with dependence or withdrawal symptoms
Framework for action for integrated care boards (ICBs) and primary care (NHS England)
Synthetic opioids will be banned as government acts to stop drug deaths
Eleven more lethal substances to be made Class A drugs, following a recommendation by the Advisory Council on the Misuse of Drugs (Home Office)
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)
Rapid Action Drug Alerts and Response (RADAR) quarterly report
The Drugs Team at Public Health Scotland (PHS) has compiled this report of drug-related indicators in order to inform action to prevent drug harms and deaths
Drug Deaths Taskforce response: cross government approach
Cross government response to the Drug Deaths Taskforce report, Changing Lives. It contains a cross government action plan, response to Taskforce recommendations and a stigma action plan (Scottish Government)
High Intensity Drug Trafficking Areas Program 2022 Report to Congress
This document presents a national overview of the HIDTA Program, including an evaluation of each HIDTA, and addresses the following three Congressional reporting requirements in one cohesive and coordinated report (White House)
Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use
The Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use in which it makes a series of recommendations on the issue (Houses of the Oireachtas, Ireland)
Cannabis in Australia
More than a third of Australians aged over 14 have used cannabis at least once – 37%, or 7.6 million people. Around 2.4 million Australians used cannabis in 2019, as did 200 million people worldwide (Penington Institute)
National naloxone programme Scotland – Quarterly monitoring bulletin
Quarterly Monitoring Bulletin April to June (Q1) 2022/23 (Public Health Scotland)
Experiences of Harm Reduction Service Providers During Dual Public Health Emergencies in Canada
This study initially set out to gain a better understanding of the effect of the overdose emergency from harm reduction service providers’ perspective. However, with the onset of COVID-19, CCSA expanded the study to identify the additional effects of dual public health emergencies (CCSA)
National Mission on Drugs: annual report 2021 to 2022
Sets out the progress made between January 2021 and 31 March 2022 by national government, local government and third sector partners towards reducing drug deaths and improving the lives of those impacted by drugs in Scotland Download (Scottish Government)
Injecting equipment provision in Scotland
This release by Public Health Scotland (PHS) presents information on injecting equipment provision (IEP). This includes the number of outlets, attendances and the types of injecting equipment distributed to people who use illicit drugs (including Novel Psychoactive Substances and Image and Performance Enhancing Drugs) in Scotland in 2021/22
Interim monitoring report on statutory funded residential rehabilitation placements
Placements approved by Alcohol and Drug Partnerships between 01 April 2021 to 30 June 2022 (Public Health Scotland)
Drug and Alcohol Treatment and Recovery Workforce Programme
This programme aims to transform the lives of those affected by drug and alcohol misuse by improving the quality and capacity of the drug and alcohol treatment and recovery workforce (NHS)
Actions Taken by the Biden-Harris Administration to Address Addiction and the Overdose Epidemic
At a time when overdose deaths, driven primarily by illicitly manufactured synthetic drugs, have reached a record high, the Biden-Harris Administration has significantly expanded access to evidence-based prevention, treatment, harm reduction, and recovery support services, as well as taken action to reduce the supply of illicit drugs like fentanyl
Irish Syringe Analysis Pilot Project
The identication of current injecting trends in the Dublin and Midland Region through the application of syringe analysis methodology (MQI)
Commissioning quality standard: alcohol and drug services
Guidance for local authorities to support them in commissioning effective alcohol and drug treatment and recovery services in their areas (Office for Health Improvement and Disparities, UK)
List of most commonly encountered drugs currently controlled under the misuse of drugs legislation
The following is a list of the most commonly encountered drugs currently controlled under the misuse of drugs legislation showing their respective classifications under both the Misuse of Drugs Act 1971 (MDA) and the Misuse of Drugs Regulations 2001 (MDR) Home Office, UK
Swift, Certain, Tough – New consequences for drug possession
Presented to Parliament by the Secretary of State for the Home Department
New Problem-Solving Courts to combat drug and alcohol-fuelled crime
Ground-breaking new courts will direct drug and alcohol abusers to tackle their addiction head-on or face tough consequences (Ministry of Justice )
National Drug Strategy Household Survey 2019
This report presents key results from the 2019 National Drug Strategy Household Survey. It looks at people’s drug use throughout their lives and during the last 12 months, and examines how these patterns have changed over time. It also asks people for their opinions on a range of initiatives designed to reduce the harm caused by tobacco, alcohol and illicit drug use, and for the first time provides perspectives on emerging initiatives, such as the availability of pill and other drug testing for potential drug users (AIHW)
Cannabis Legalization: 2021–2022 Observations (Policy Brief)
Examines evidence on the impact and implementation of the 2018 Cannabis Act. The report explores progress toward the act’s public health and safety objectives. Policy makers, public health professionals and researchers involved in cannabis regulation will find the report informative (CCSA)
A review of UK public policy; regulatory stewardship of the legal cannabis industry
In February this year following a series of meetings with Ministers, advisers and senior officials in Whitehall the Centre of Medicinal Cannabis and the Association for the Cannabinoid Industry commissioned Oxford University’s Professor Christopher Hodges to oversee a comprehensive review of the UK legal cannabinoid industry with a particular regard to how public policy and regulation can support the sector’s growth and development (Hodges Review, UK)
Giving Drug Policy Decisionmakers the Data They Need
Testimony submitted to the U.S. Senate Caucus on International Narcotics Control on June 22, 2022 (RAND)
2022 National Drug Control Strategy
This inaugural Strategy proposes bold, targeted, and consequential actions to bend the curve on overdose deaths in the immediate term and reduce drug use and its damaging consequences over the longer term (White House)
Drug checking in Australia: how far do we have to go?
This presentation focused on drug checking or pill testing services, which have existed for over 50 years and now operate in more than 20 countries. Despite this long history, little research assessing feasibility or impact has been published in peer-reviewed journals (NDARC)
Alcohol and other drug treatment services in Australia: early insights
Alcohol and other drug treatment services in Australia: early insights presents key statistics about Australia’s publicly funded alcohol and other drug treatment services and their clients. Early insights is a companion report to the data and analysis presented in Alcohol and other drug treatment services in Australia: annual report (AIHW)
Extra funding for drug and alcohol treatment: 2022 to 2023
Information about new funding to local councils to help them improve their drug and alcohol treatment and recovery systems (UK Government)
Needle Exchange Surveillance Initiative (NESI)
Prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs attending injecting equipment provision services in Scotland, 2008 to 2020 (Public Health Scotland)
Treatment target for people with problematic drug use
A national target will be introduced to ensure more people with problematic opiate drug use are accessing life-saving community treatments (Scottish Government)
Reducing Drug Deaths in London
London Assembly Health Committee
Evaluation of the Pharmaceutical Benefits Scheme subsidised take home naloxone pilot
This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021 (Australian Government)
Government response letter to the ACMD on CBPMs in humans
Four recommendations
ACMD annual report 2017 to 2019
Provides a summary of the main issues the ACMD considered between January 2017 and December 2019
ACMD advice on consumer cannabidiol (CBD) products
Report from the Advisory Council on the Misuse of Drugs (ACMD) on consumer cannabidiol (CBD) products
From harm to hope: A 10-year drugs plan to cut crime and save lives
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system (Home Office)
Women’s Report
In February 2021, the Taskforce had a discussion about the particular issues facing women who use drugs and their families – download (Scottish Drug Deaths Taskforce)
Inquiry into the Drugs of Dependence (Personal Use) Amendment Bill 2021
Legislative Assembly for the Australian Capital Territory Select Committee on the Drugs of Dependence (Personal Use) Amendment Bill 2021
SAMHSA Extends the Methadone Take-Home Flexibility for One Year While Working Toward a Permanent Solution
The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the methadone take-home flexibilities for one year, effective upon the eventual expiration of the COVID-19 Public Health Emergency (SAMHSA)
- 1
- 2
- 3
- …
- 11
- Next Page »
